World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
Italy
2026
Award Badge
Genetics and Molecular Biology
Italy
2024

D-Index & Metrics

Molecular Biology

D-Index
132
Citations
59546
World Ranking
176
National Ranking
2

Paolo M. Comoglio publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Paolo M. Comoglio sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 515 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Paolo M. Comoglio D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Paolo M. Comoglio sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 132 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Italy Leader Award
  • 2025 - Research.com Molecular Biology in Italy Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in Italy Leader Award
  • 2023 - Research.com Genetics and Molecular Biology in Italy Leader Award
  • 2023 - Research.com Molecular Biology in Italy Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in Italy Leader Award
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Paolo M. Comoglio is affiliated with the University of Turin in Italy. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus on Medicine. Comoglio's work further specializes in subfields such as Molecular Biology, Oncology, Hepatology, Cancer Research, and Pathology and Forensic Medicine.

The scientist's main research topics include:

  • Liver physiology and pathology
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer Diagnosis and Treatment
  • Tumors and Oncological Cases
  • Oral and Maxillofacial Pathology
  • Cancer, Hypoxia, and Metabolism
  • Cancer Cells and Metastasis

Comoglio has contributed to several recent publications, exemplifying a focus on cancer biology, signaling pathways, and therapeutic vulnerabilities. Selected recent papers include:

  • Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition (2021), Nature Communications
  • ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma (2021), Cell Reports
  • Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro (2020), British Journal of Pharmacology
  • Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) (2022), Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers (2022), Journal of Experimental & Clinical Cancer Research

Frequent co-authors collaborating with Comoglio include:

  • Carla Boccaccio
  • Federica Verginelli
  • Alberto Pisacane
  • Gennaro Gambardella
  • Antonio D'Ambrosio

Comoglio's work is often published in notable scientific venues, with multiple publications in the following journals:

  • Cell Reports
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Journal of Experimental & Clinical Cancer Research
  • EMBO Molecular Medicine
  • Cancer Research

Among distinctions, Paolo M. Comoglio has been recognized as a Member of the European Molecular Biology Organization (EMBO).

Best Publications

  • Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

    F Bussolino;M F Di Renzo;M Ziche;E Bocchietto

  • Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

    Selma Pennacchietti;Paolo Michieli;Maria Galluzzo;Massimiliano Mazzone

  • Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.

    Luca Tamagnone;Stefania Artigiani;Hang Chen;Zhigang He

  • MET signalling: principles and functions in development, organ regeneration and cancer.

    Livio Trusolino;Andrea Bertotti;Paolo M. Comoglio

  • A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

    Carola Ponzetto;Alberto Bardelli;Alberto Bardelli;Zhu Zhen;Flavio Maina

  • Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): A proof-of-concept, multicentre, open-label, phase 2 trial

    Andrea Sartore-Bianchi;Livio Trusolino;Cosimo Martino;Katia Bencardino

  • A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

    Andrea Bertotti;Giorgia Migliardi;Francesco Galimi;Francesco Sassi

  • Drug development of MET inhibitors : targeting oncogene addiction and expedience

    Paolo M. Comoglio;Silvia Giordano;Livio Trusolino

  • Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

    L Naldini;E Vigna;R P Narsimhan;G Gaudino

  • Scatter-factor and semaphorin receptors: cell signalling for invasive growth

    Livio Trusolino;Paolo M. Comoglio

  • Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

    L. Naldini;K.M. Weidner;E. Vigna;G. Gaudino

  • Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

    Luigi Naldini;Luca Tamagnone;Elisa Vigna;Martin Sachs

  • Invasive growth: a MET-driven genetic programme for cancer and stem cells

    Carla Boccaccio;Paolo M. Comoglio

  • Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells.

    A J Ridley;P M Comoglio;A Hall

  • Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

    Carla Boccaccio;Margherita Andò;Luca Tamagnone;Alberto Bardelli

  • Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

    Alberto Bardelli;Simona Corso;Andrea Bertotti;Sebastijan Hobor

  • Expression of the Met/HGF receptor in normal and neoplastic human tissues.

    M. F. Di Renzo;R. P. Narsimhan;M. Olivero;S. Bretti

  • Tyrosine kinase receptor indistinguishable from the c-met protein.

    S. Giordano;C. Ponzetto;M. F. Di Renzo;C. S. Cooper

  • A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth

    Livio Trusolino;Andrea Bertotti;Paolo M Comoglio

  • Plexin A Is a Neuronal Semaphorin Receptor that Controls Axon Guidance

    Margaret L Winberg;Jasprina N Noordermeer;Luca Tamagnone;Paolo M Comoglio

Frequent Co-Authors

Silvia Giordano
Silvia Giordano University of Turin
Alberto Bardelli
Alberto Bardelli University of Turin
Enzo Medico
Enzo Medico University of Turin
Luigi Naldini
Luigi Naldini Vita-Salute San Raffaele University
Luca Tamagnone
Luca Tamagnone Catholic University of the Sacred Heart
Giovanni Gaudino
Giovanni Gaudino University of Hawaii at Manoa
Guido Tarone
Guido Tarone University of Turin
Filippo G. Giancotti
Filippo G. Giancotti Columbia University
Pier Carlo Marchisio
Pier Carlo Marchisio Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Molecular Biology can open doors to a range of healthcare and scientific careers. Many students build on their background by exploring advanced or related healthcare degrees online. For example, if you're considering a career shift, direct entry msn online programs allow non-nurses to transition quickly into nursing, leveraging their science knowledge.

For those already in nursing, comparing schools is vital. This wgu vs chamberlain guide shows key differences among popular online RN to BSN programs, helping you select the best fit for your goals.

If you have a BSN degree, consider advancing with flexible, affordable bsn to msn online bridge programs—ideal for moving into leadership, research, or specialized clinical roles.

Finally, when selecting an institution, check accreditation status to ensure quality and recognition. Many students prefer non profit colleges for their reputation and student-focused approach. Exploring these online education pathways can complement your molecular biology background and broaden your career options in healthcare and beyond.

Best Scientists Citing Paolo M. Comoglio

Trending Scientists

Recently Published Articles